NCT03117673

Brief Summary

Transesophageal echocardiography (TEE) plays an important role in intraoperative monitoring and can be used to estimate pulmonary artery pressures. An excellent correlation between right ventricular systolic pressure (RVSP) measured by right heart catheterization (RHC) and simultaneously estimated by transthoracic echocardiography is reported and also implemented into the current guidelines for the echocardiographic assessment of the right heart in adults by the American Society of Echocardiography. So far there are no studies evaluating RVSP measured by transesophageal echocardiography (TEE) and recommendations are unclear which transesophageal view is the best for calculation. We want to assess if there is a difference in the systolic pulmonary artery pressure measured invasively with a pulmonary artery catheter (PAC) and the calculated right ventricular systolic pressure (RVSP) using transesophageal echocardiography (TEE) in 3 different views: ME 4Ch, ME RV inflow-outflow, ME modified bicaval.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 18, 2017

Completed
13 days until next milestone

Study Start

First participant enrolled

May 1, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

October 20, 2017

Status Verified

October 1, 2017

Enrollment Period

2.7 years

First QC Date

April 6, 2017

Last Update Submit

October 19, 2017

Conditions

Keywords

right ventricular systolic pressure (RVSP)Transesophageal echocardiography

Outcome Measures

Primary Outcomes (1)

  • RVSP calculated from TEE measurements

    Bias and precision of RVSP calculated from TEE measurements as compared to measured systolic pulmonary artery pressure with PAC

    during routine transesophageal echocardiography examination

Secondary Outcomes (1)

  • Differences in bias and precision between patients with normal, and elevated mean PAP, and those with severe TI

    during routine transesophageal echocardiography examination

Study Arms (3)

group 1

Patients with mild to moderate TI and normal RVSP (\< 40mmHg) and mean PAP (\< 25mmHg)

Other: transesophageal echocardiography measurements

group 2

Patients with mild to moderate TI and elevated RVSP (\> 40mmHg) and mean PAP (\> 25mmHg)

Other: transesophageal echocardiography measurements

group 3

Patients with severe TI (defined as Vena contracta \> or equal 7mm, reversed systolic hepatic vein flow, proximal isovelocity surface area (PISA) radius \> 9 mm, and very large central jet or eccentric wall impinging jet)

Other: transesophageal echocardiography measurements

Interventions

transesophageal echocardiography will be done routinely during the procedure. We will do additional measurements of the maximal TR velocity

group 1group 2group 3

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

39 patients scheduled for cardiac operation in general anaesthesia divided in 3 groups (13 per group): I. Patients with mild to moderate TI and normal RVSP (\< 40mmHg) and mean PAP (\< 25mmHg) II. Patients with mild to moderate TI and elevated RVSP (\> 40mmHg) and mean PAP (\> 25mmHg) Patients with severe TI (defined as Vena contracta \> or equal 7mm, reversed systolic hepatic vein flow, proximal isovelocity surface area (PISA) radius \> 9 mm, and very large central jet or eccentric wall impinging jet)

You may qualify if:

  • Elective cardiac surgery in general anaesthesia
  • Transesophageal echocardiography (TEE) indicated
  • Pulmonary artery catheter (PAC) indicated

You may not qualify if:

  • Age \< 18 years
  • Atrial fibrillation
  • Declined informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical university of vienna, General hospital of Vienna

Vienna, 1090, Austria

RECRUITING

Study Officials

  • Ulrike Weber, M.D.

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ass.Prof.Dr.

Study Record Dates

First Submitted

April 6, 2017

First Posted

April 18, 2017

Study Start

May 1, 2017

Primary Completion

December 31, 2019

Study Completion

December 31, 2020

Last Updated

October 20, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations